976 related articles for article (PubMed ID: 26547257)
1. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.
Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW
J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
3. Phototherapy for mycosis fungoides.
Dogra S; Mahajan R
Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
[TBL] [Abstract][Full Text] [Related]
4. Phototherapy of Mycosis Fungoides.
Hodak E; Pavlovsky L
Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
[TBL] [Abstract][Full Text] [Related]
5. Nb-UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single-center cross-sectional study.
Zengarini C; Baruffaldi G; Piraccini BM; Bardazzi F; Mussi M; Hrvatin Stancic B; Pileri A
Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):435-440. PubMed ID: 36974002
[TBL] [Abstract][Full Text] [Related]
6. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
[TBL] [Abstract][Full Text] [Related]
7. Phototherapy for cutaneous T-cell lymphoma.
Baron ED; Stevens SR
Dermatol Ther; 2003; 16(4):303-10. PubMed ID: 14686973
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.
Berg S; Villasenor-Park J; Haun P; Kim EJ
Curr Hematol Malig Rep; 2017 Jun; 12(3):234-243. PubMed ID: 28540671
[TBL] [Abstract][Full Text] [Related]
9. Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas.
Grandi V; Fava P; Rupoli S; Alberti Violetti S; Canafoglia L; Quaglino P; Berti E; Pimpinelli N;
J Eur Acad Dermatol Venereol; 2018 May; 32(5):683-691. PubMed ID: 29105200
[TBL] [Abstract][Full Text] [Related]
10. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
[TBL] [Abstract][Full Text] [Related]
11. Phototherapy of mycosis fungoides.
Trautinger F
G Ital Dermatol Venereol; 2017 Dec; 152(6):597-606. PubMed ID: 28845954
[TBL] [Abstract][Full Text] [Related]
12. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses.
Gettler SL; Fung MA
Dermatol Online J; 2005 Dec; 11(3):6. PubMed ID: 16409902
[TBL] [Abstract][Full Text] [Related]
15. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
[TBL] [Abstract][Full Text] [Related]
17. Phototherapy of cutaneous T-cell lymphomas.
Trautinger F
Photochem Photobiol Sci; 2018 Dec; 17(12):1904-1912. PubMed ID: 30325389
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
19. Childhood mycosis fungoides: experience of 28 patients and response to phototherapy.
Laws PM; Shear NH; Pope E
Pediatr Dermatol; 2014; 31(4):459-64. PubMed ID: 24916067
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
Parker SR; Bethaney JV
G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
